|Bid||153.25 x 800|
|Ask||153.30 x 1000|
|Day's Range||150.88 - 159.60|
|52 Week Range||19.31 - 189.26|
|Beta (5Y Monthly)||1.50|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 05, 2021 - May 10, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||160.38|
J&J's vaccine recommended for emergency use authorization by independent experts. FDA will make a decision this weekend.Johnson & Johnson's (JNJ) single-dose COVID-19 vaccine is one step closer to emergency use authorization (EAU) after an independent panel voted Friday to recommend the U.S. Food and Drug Administration (FDA) issue the EUA.
Mass vaccinations are necessary to keep Covid-19 at bay. But there’s a lot more than just vaccines in pharma and biotech pipelines.
Regulator could approve It as soon as Saturday, joining authorized vaccines from Pfizer and Moderna.